|
|
|
|
• ADAPT
|
|
 |
MUST was a multicenter, randomized controlled clinical trial, that will compare the fluocinolone acetonide implant to standard systemic therapy for the treatment of patients with non-infectious intermediate uveitis, posterior uveitis, or panuveitis.
